Found 8 matching trials
A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer
EARLY_PHASE1This study is evaluating stereotactic radiosurgery (CyberKnife) plus chemot...
Location
MD Anderson Cancer Center at Cooper
Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
PHASE1The purpose of this study is to evaluate the efficacy and safety of stereot...
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
SBRT Plus Pembrolizumab and Trametinib for Pancreatic Cancer
PHASE2Hypothesis: Survival benefits could be found in SBRT Plus Pembrolizumab and...
Location
Changhai hospital
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
PHASE2The current study seeks to further investigate the impact of up-front syste...
Location
UPMC Cancer Centers
Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
NAThe aim of this study is to compare the safety and efficacy of SBRT in LAPC...
Location
Changhai hospital
Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma
PHASE2This multi-institutional trial aims to evaluate the potential benefit and s...
Location
Stanford University School of Medicine
Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
PHASE2The purpose of this study is to assess surgical conversion rate and the imm...
Location
Fourth Hospital of Hebei Medical University
Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)
PHASE1This study is looking at determining the maximum safe dose of CyberKnife wh...
Location
MD Anderson Cancer Center at Cooper